Abrogation of SHP-1 in tumor-specific effector T cells during adoptive immunotherapy of disseminated leukemia

被引：0
|
作者：
Stromnes, Ingunn [1 ]
Fowel, Carla [1 ]
Blattman, Joseph [1 ,2 ]
Tan, Xiaoxia [1 ]
Greenberg, Philip [1 ,2 ]
机构：
[1] Univ Washington, Immunol, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
来源：
JOURNAL OF IMMUNOLOGY | 2010年 / 184卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
131.15
引用
收藏
页数：1
相关论文
共 50 条
  • [21] WILMS' TUMOR 1 (WT1)-SPECIFIC T LYMPHOCYTES AS A TOOL FOR ADOPTIVE IMMUNOTHERAPY IN ACUTE MYELOID LEUKEMIA
    Danielzik, Tina
    Buttkereit, U.
    Beelen, D. W.
    Horn, P. A.
    Lindemann, M.
    ANNALS OF HEMATOLOGY, 2013, 92 : S4 - S4
  • [22] Purity of transferred CD8+ T cells is crucial for safety and efficacy of combinatorial tumor immunotherapy in the absence of SHP-1
    Watson, H. Angharad
    Dolton, Garry
    Ohme, Julia
    Ladell, Kristin
    Vigar, Miriam
    Wehenkel, Sophie
    Hindley, James
    Mohammed, Rebar N.
    Miners, Kelly
    Luckwell, Rhys A.
    Price, David A.
    Matthews, R. James
    Ager, Ann
    IMMUNOLOGY AND CELL BIOLOGY, 2016, 94 (08): : 802 - 808
  • [23] Adoptive immunotherapy with tumor-specific T lymphocytes generated from cytokine gene-modified tumor-primed lymph node cells
    Ohno, K
    Yoshizawa, H
    Tsukada, H
    Takeda, T
    Yamaguchi, Y
    Ichikawa, K
    Maruyama, Y
    Suzuki, Y
    Suzuki, E
    Arakawa, M
    JOURNAL OF IMMUNOLOGY, 1996, 156 (10): : 3875 - 3881
  • [24] Adoptive Transfer of Tumor-Specific Tc17 Effector T Cells Controls the Growth of B16 Melanoma in Mice
    Garcia-Hernandez, Maria de la Luz
    Hamada, Hiromasa
    Reome, Joyce B.
    Misra, Sara K.
    Tighe, Michael P.
    Dutton, Richard W.
    JOURNAL OF IMMUNOLOGY, 2010, 184 (08): : 4215 - 4227
  • [25] SPECIFIC ADOPTIVE IMMUNOTHERAPY WITH TUMOR-SPECIFIC CYTO-TOXIC T-LYMPHOCYTE CLONE FOR MURINE MALIGNANT GLIOMAS
    YAMASAKI, T
    HANDA, H
    YAMASHITA, J
    WATANABE, Y
    NAMBA, Y
    HANAOKA, M
    CANCER RESEARCH, 1984, 44 (05) : 1776 - 1783
  • [26] Human effector T cells derived from central memory cells rather than CD8+T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy
    Wu, Fenglin
    Zhang, Wenfeng
    Shao, Hongwei
    Bo, Huaben
    Shen, Han
    Li, Jiandong
    Liu, Yichen
    Wang, Teng
    Ma, Wenli
    Huang, Shulin
    CANCER LETTERS, 2013, 339 (02) : 195 - 207
  • [27] Ex vivo-induction of tumor-specific effector and memory T cells for adoptive T cell therapies using antigen-loaded DCs
    Hansen, Morten
    Wieckowski, Eva
    Kalinski, Pawel
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [28] Ex vivo characterization of multiepitopic tumor-specific CD8 T cells in patients with chronic myeloid leukemia:: Implications for vaccine development and adoptive cellular immunotherapy
    Gannagé, M
    Abel, M
    Michallet, AS
    Delluc, S
    Lambert, M
    Giraudier, S
    Kratzer, R
    Niedermann, G
    Saveanu, L
    Guilhot, F
    Camoin, L
    Varet, B
    Buzyn, A
    Caillat-Zucman, S
    JOURNAL OF IMMUNOLOGY, 2005, 174 (12): : 8210 - 8218
  • [29] IMMUNOSTIMULATORY PHOTOTHERMAL PRUSSIAN BLUE NANOPARTICLES ENGINEER TUMOR-SPECIFIC T CELLS FOR ADOPTIVE THERAPY
    Sweeney, E. E.
    Sekhri, P.
    Muniraj, N.
    Chen, J.
    Bollard, C.
    Sanchez, C.
    Cruz, C.
    Fernandes, R.
    CYTOTHERAPY, 2023, 25 (06) : S8 - S8
  • [30] Self-specific memory regulatory T-cells outrun tumor-specific effector T-cells at tumor emergence to impose tumor tolerance
    Podsypanina, Katrina
    JOURNAL OF IMMUNOLOGY, 2011, 186
12345